HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Free Full Text (PDF) Free Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Recchia, F. A. Articles by Hintze, T. H. Search for Related Content PubMed PubMed Citation Articles by Recchia, F. A. Articles by Hintze, T. H.

---

Original Article

Cytokines Are Not a Requisite Part of the Pathophysiology Leading to Cardiac Decompensation

Fabio A. Recchia^*, Robert D. Bernstein^*, Pravin B. Sehgal, Nicholas R. Ferreri and Thomas H. Hintze^*,1

^* Department of Physiology,
Department of Anatomy and Cell Biology, and
Department of Pharmacology, New York Medical College, Valhalla, New York 10595

An increase in circulating levels of proinflammatory cytokines has been proposed as an important pathogenic factor contributing to cardiac injury during chronic heart failure. To determine whether plasma levels of the cytokines tumor necrosis factor- (TNF-) and interleukin-6 (IL-6) increase during pacing-induced heart failure, we paced the hearts of seven dogs at 210 beats/min for 3 weeks and at 240 beats/min for an additional week to induce severe clinical signs of cardiac decompensation. Hemodynamic measurements and blood samples from the aorta and coronary sinus (CS) were taken at control, at 3 weeks, and in end-stage failure. Decompensated heart failure occurred at 29 ± 1.8 days, when left ventricular (LV) end-diastolic pressure was 25 ± 1.3 mmHg, LV systolic pressure was 92 ± 4 mmHg, mean arterial pressure was 77 ± 3 mmHg, and dP/dt_max was 1219 ± 73 (all P < 0.05 vs control). Arterial concentration of IL-6 was 12 ± 4.0 U/ml at control, 11 ± 2.7 U/ml at 3 weeks, and 10 ± 1.7 U/ml in end-stage failure (NS). At the same time points, IL-6 in CS plasma was 12 ± 3.5, 13 ± 2.8 and 11 ± 2.4 U/ml, respectively (NS vs control and vs arterial concentrations). TNF- did not reach detectable concentrations in arterial or CS blood at any time. TNF- and IL-6 concentrations did not increase in arterial blood, were not released in the CS from the heart during the development of pacing-induced heart failure, and can not universally be implicated in the pathogenesis of all forms of cardiac dysfunction. Our findings are consistent with other data from patients in which severe heart failure was not associated with increased levels of circulating cytokines.

This article has been cited by other articles:

				S. Aker, S. Belosjorow, I. Konietzka, A. Duschin, C. Martin, G. Heusch, and R. Schulz Serum but not myocardial TNF-{alpha} concentration is increased in pacing-induced heart failure in rabbits Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2003; 285(2): R463 - R469. [Abstract] [Full Text] [PDF]

				D. L. Brutsaert Cardiac Endothelial-Myocardial Signaling: Its Role in Cardiac Growth, Contractile Performance, and Rhythmicity Physiol Rev, January 1, 2003; 83(1): 59 - 115. [Abstract] [Full Text] [PDF]

				J. H. Traverse, Y. Chen, M. Hou, and R. J. Bache Inhibition of NO production increases myocardial blood flow and oxygen consumption in congestive heart failure Am J Physiol Heart Circ Physiol, June 1, 2002; 282(6): H2278 - H2283. [Abstract] [Full Text] [PDF]